Century Therapeutics Inc (IPSC)

03:27 AM

66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World

03:27 AM

Jun 10, 2025

Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 10, 2025

Jun 09, 2025

Century Therapeutics, Inc. (NASDAQ:IPSC) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 09, 2025

Jun 09, 2025

Two Sigma Advisers LP Takes $52,000 Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 09, 2025

Jun 07, 2025

Nuveen Asset Management LLC Raises Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 07, 2025

Jun 06, 2025

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain - sharewise

Jun 06, 2025

Jun 04, 2025

Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN

Jun 04, 2025

Jun 03, 2025

Deutsche Bank AG Purchases 173,849 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 03, 2025

Jun 03, 2025

Millennium Management LLC Grows Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 03, 2025

May 30, 2025

Q2 EPS Estimate for Century Therapeutics Raised by Analyst - Defense World

May 30, 2025

May 29, 2025

Brokers Issue Forecasts for IPSC Q1 Earnings - Defense World

May 29, 2025

May 28, 2025

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress - GlobeNewswire

May 28, 2025

May 23, 2025

Chardan Capital Issues Optimistic Forecast for IPSC Earnings - Defense World

May 23, 2025

May 22, 2025

Leerink Partnrs Has Negative Forecast for IPSC Q2 Earnings - Defense World

May 22, 2025

May 19, 2025

Century Therapeutics Reports Strong Q1 2025 Earnings - TipRanks

May 19, 2025

May 19, 2025

Century Therapeutics Reports Positive Q1 2025 Results and Advances in Cell Therapy Pipeline - MSN

May 19, 2025

May 19, 2025

Chardan Trims Price Target on Century Therapeutics to $6 From $7, Maintains Buy Rating - marketscreener.com

May 19, 2025

May 18, 2025

Chardan Capital Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $6.00 - Defense World

May 18, 2025

May 16, 2025

Chardan Capital Lowers Price Target for Century Therapeutics (IP - GuruFocus

May 16, 2025

May 16, 2025

Chardan Capital Lowers Price Target for Century Therapeutics (IPSC) | IPSC Stock News - GuruFocus

May 16, 2025

May 16, 2025

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 16, 2025

May 15, 2025

Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates - sharewise

May 15, 2025

May 15, 2025

Century Therapeutics Expands iPSC Cell Therapy to Europe as Q1 Revenue Surges to $109M - Stock Titan

May 15, 2025

May 07, 2025

Marshall Wace LLP Purchases New Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

May 07, 2025

May 05, 2025

JPMorgan Chase & Co. Buys 91,468 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

May 05, 2025

May 02, 2025

A closer look at Century Therapeutics Inc (IPSC)’s stock price trends - uspostnews.com

May 02, 2025

May 02, 2025

Geode Capital Management LLC Acquires 23,413 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

May 02, 2025

May 01, 2025

Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting - MSN

May 01, 2025

May 01, 2025

Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 01, 2025

May 01, 2025

Century Therapeutics (IPSC) Expected to Announce Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

An Analysis of Century Therapeutics Inc (IPSC)’s Potential Price Growth - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

Renaissance Technologies LLC Boosts Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Apr 30, 2025

Apr 29, 2025

Market Insight: Century Therapeutics Inc (IPSC)’s Notable Drop, Closing at 0.50 - DWinneX

Apr 29, 2025

Apr 28, 2025

Century Therapeutics to Present Preclinical Data at ASGCT 28th Annual Meeting on Novel iPSC-Derived Cell Therapies for Autoimmune Diseases and Cancer - Nasdaq

Apr 28, 2025

Apr 28, 2025

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting - GlobeNewswire

Apr 28, 2025

Apr 28, 2025

Century Therapeutics Reveals Groundbreaking Cancer-Fighting Cell Therapy Data at Major Scientific Conference - Stock Titan

Apr 28, 2025

Apr 24, 2025

IPSCCentury Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 24, 2025

Is it possible to buy Century Therapeutics Inc(IPSC) shares at a good price now? - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Century Therapeutics Inc (IPSC): A Sitting Duck With -825.93% Upside Potential - Stocksregister

Apr 24, 2025

Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock - Investing.com

Apr 24, 2025

Apr 24, 2025

Century Therapeutics Inc (IPSC)’s financial ratios: A comprehensive overview - DWinneX

Apr 24, 2025

Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock By Investing.com - Investing.com UK

Apr 24, 2025

Apr 23, 2025

Century Therapeutics Inc [IPSC] Stock sold by Insider Pfeiffenberger Brent for $1375.0 - knoxdaily.com

Apr 23, 2025

Apr 20, 2025

Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances - MSN

Apr 20, 2025

Apr 15, 2025

Century Therapeutics to Host Live Chat on Preclinical Cell Therapy Programs Targeting Autoimmune Diseases and Cancer - Nasdaq

Apr 15, 2025

Apr 15, 2025

Century Therapeutics to Host Live Fireside Chat Focused on - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

Century Therapeutics Unveils Next-Gen Cell Therapy Pipeline for Cancer and Autoimmune | IPSC Stock News - Stock Titan

Apr 15, 2025

Apr 15, 2025

American Century Companies Inc. Buys Shares of 105,337 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

Apr 15, 2025